Evidence map›Paper›PMID 23509801›Full record

ArticleBioMed research international2013

Synthesis and antimicrobial activity of silver-doped hydroxyapatite nanoparticles.

Carmen Steluta Ciobanu, Simona Liliana Iconaru, Mariana Carmen Chifiriuc, Adrian Costescu, Philippe Le Coustumer, Daniela Predoi

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 160 citations in OpenAlex.

  1. Co-Doped (NaChemistryOpen · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Ag/AgMaterials (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Biocompatible Piezoelectric PVDF/HA/AgNOSensors (Basel, Switzerland) · 2022
    Article
  11. Nanocomposite Based on HA/PVTMS/ClSensors (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Carmen Steluta CiobanuDepartment of Multifunctional Materials and Structures Laboratory, National Institute of Materials Physics, 105 Bis Atomistilor, P.O. Box MG 07, 077125 Magurele, Romania.
Simona Liliana Iconaru
Mariana Carmen Chifiriuc
Adrian Costescu
Philippe Le Coustumer
Daniela Predoi
University of Bucharest · RONational Institute of Materials Physics · ROUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis of nanosized particles of Ag-doped hydroxyapatite with antibacterial properties is of great interest for the development of new biomedical applications. The aim of this study was the evaluation of Ca(10-x)Ag(x)(PO4)6(OH)2 nanoparticles (Ag:HAp-NPs) for their antibacterial and antifungal activity. Resistance to antimicrobial agents by pathogenic bacteria has emerged in the recent years and became a major health problem. Here, we report a method for synthesizing Ag doped nanocrystalline hydroxyapatite. A silver-doped nanocrystalline hydroxyapatite was synthesized at 100°C in deionised water. Also, in this paper Ag:HAp-NPs are evaluated for their antimicrobial activity against gram-positive and gram-negative bacteria and fungal strains. The specific antimicrobial activity revealed by the qualitative assay is demonstrating that our compounds are interacting differently with the microbial targets, probably due to the differences in the microbial wall structures.

Indexed as

Anti-Infective AgentsBiofilmsDrug DesignDurapatiteFungiGram-Negative BacteriaGram-Positive BacteriaMicrobial Sensitivity TestsMicroscopy, Electron, ScanningMicroscopy, Electron, TransmissionNanoparticlesSilverSpectrophotometry, InfraredX-Ray DiffractionAnti-Infective AgentsDurapatiteSilver

Identifiers

PMID23509801
PMCPMC3591194
OpenAlexW1965748848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.